Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/REGENXBIO-INC-23733717/news/REGENXBIO-Inc-Announces-Pivotal-Trial-of-RGX-121-for-the-Treatment-of-MPS-II-Achieves-Primary-Endpo-45907871/?utm_source=whatsapp&utm_medium=social&utm_campaign=share